Search hospitals > Oklahoma > Tulsa
Oklahoma Cancer Specialists and Research Institute-Tulsa
Claim this profileTulsa, Oklahoma 74146
Global Leader in Cancer
Global Leader in Recurrence
Conducts research for Ovarian Cancer
Conducts research for Adenocarcinoma
Conducts research for Fallopian Tube Cancer
257 reported clinical trials
27 medical researchers
Summary
Oklahoma Cancer Specialists and Research Institute-Tulsa is a medical facility located in Tulsa, Oklahoma. This center is recognized for care of Cancer, Recurrence, Ovarian Cancer, Adenocarcinoma, Fallopian Tube Cancer and other specialties. Oklahoma Cancer Specialists and Research Institute-Tulsa is involved with conducting 257 clinical trials across 440 conditions. There are 27 research doctors associated with this hospital, such as Debra L. Richardson, Kathleen Moore, M.D., MS, Raid Aljumaily, and Wajeeha Razaq, MD.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Recurrence
Global LeaderStage IV
Stage III
BRCA1 positive
Top PIs
Debra L. RichardsonUniversity of Oklahoma Health Sciences Center1 year of reported clinical research
Expert in Ovarian Cancer
Expert in Cancer
31 reported clinical trials
50 drugs studied
Kathleen Moore, M.D., MSUniversity of Oklahoma Health Sciences Center4 years of reported clinical research
Expert in Ovarian Cancer
Expert in Ovarian Tumors
29 reported clinical trials
81 drugs studied
Raid AljumailyUniversity of Oklahoma Health Sciences Center7 years of reported clinical research
Expert in Non-Small Cell Lung Cancer
Expert in Lung Cancer
24 reported clinical trials
40 drugs studied
Wajeeha Razaq, MDUniversity of Oklahoma Health Sciences Center1 year of reported clinical research
Expert in Breast Cancer
Studies Cancer
23 reported clinical trials
45 drugs studied
Clinical Trials running at Oklahoma Cancer Specialists and Research Institute-Tulsa
Bladder Cancer
Breast Cancer
Cancer
Non-Small Cell Lung Cancer
Bladder Carcinoma
Ovarian Cancer
Renal Cell Carcinoma
Lung Cancer
Colorectal Cancer
Endometrial Cancer
TROP2 ADC
for Cancer
Recruiting1 award Phase 1 & 213 criteria
MK-7684A
for Advanced Cancers
This study is evaluating whether a combination of a drug and a light therapy is better than a drug alone in treating cancer.
Recruiting1 award Phase 27 criteria
Immunotherapy + Targeted Therapy
for Genitourinary Cancers
This study is evaluating whether a combination of drugs may help treat patients with rare tumors.
Recruiting1 award Phase 221 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Oklahoma Cancer Specialists and Research Institute-Tulsa?
Oklahoma Cancer Specialists and Research Institute-Tulsa is a medical facility located in Tulsa, Oklahoma. This center is recognized for care of Cancer, Recurrence, Ovarian Cancer, Adenocarcinoma, Fallopian Tube Cancer and other specialties. Oklahoma Cancer Specialists and Research Institute-Tulsa is involved with conducting 257 clinical trials across 440 conditions. There are 27 research doctors associated with this hospital, such as Debra L. Richardson, Kathleen Moore, M.D., MS, Raid Aljumaily, and Wajeeha Razaq, MD.